United States
BioGenerator is an evergreen investor that creates, grows, and funds innovative companies and talented entrepreneurs in the St. Louis region. BioGenerator identifies and de-risks commercially promising innovations and services; advises innovators and entrepreneurs; recruits and supports entrepreneurial talent; makes staged investments grounded in rigorous due diligence; and offers access to enabling lab space and capital equipment. We position companies to navigate the unique challenges of early-stage bioscience company development. BioGenerator is the investment arm of BioSTL
54
Total Investments
38
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Pharmaceutical
Funding Stage
Seed +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About BioGenerator
Recent Investments (54)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Seed | •••••• | Jul 2024 | |
| Series A | •••••• | Aug 2023 | |
| Seed | •••••• | Mar 2023 | |
| Series A | •••••• | Mar 2023 | |
| Seed Round | •••••• | Dec 2022 | |
•••• ••••
|
Pre Seed Round | •••••• | Nov 2022 |
|
•••• ••••
|
Series A | •••••• | Nov 2021 |
|
•••• ••••
|
Series B | •••••• | Nov 2021 |
|
•••• ••••
|
Grant | •••••• | Sep 2021 |
|
•••• ••••
|
Seed Round | •••••• | Jun 2021 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
